Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/30/2002CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/28/2002WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002WO2002095051A2 Mage-a3 peptides presented by hla class ii molecules
11/28/2002WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002WO2002095030A2 Modulation of cd200 receptors
11/28/2002WO2002095028A1 Polynucleotide probe and primer for detecting beer-clouding lactic acid bacteria and method of detecting beer-clouding lactic acid bacteria
11/28/2002WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002WO2002095003A2 Phytases, nucleic acids encoding them and methods for making and using them
11/28/2002WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002WO2002094985A2 Beta-secretase substrates and uses thereof
11/28/2002WO2002094983A2 Dna-antibody complexes to enhance gene transfer
11/28/2002WO2002094881A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002WO2002094880A1 Anti-trail-r antibodies
11/28/2002WO2002094879A1 Antibodies specific for cd44v6
11/28/2002WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002WO2002094874A2 Internalisation of virus into cells
11/28/2002WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002WO2002094865A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology
11/28/2002WO2002094864A2 Human cdnas and proteins and uses thereof
11/28/2002WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002WO2002094862A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002WO2002094861A2 Genes and proteins involved in the biosynthesis of enediyne ring structures
11/28/2002WO2002094854A2 P.aeruginosa mucoid exopolysaccharide specific binding peptides
11/28/2002WO2002094853A2 Antibodies specific for poly(ethylene glycol)
11/28/2002WO2002094852A2 Taci-immunoglobulin fusion proteins
11/28/2002WO2002094780A2 Kinases and phosphatases
11/28/2002WO2002094317A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002WO2002094194A2 Compositions and methods for inhibiting metastasis
11/28/2002WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002WO2002094124A2 Method of increasing uniformity in avians
11/28/2002WO2002094029A1 Method of inhibiting fungal growth
11/28/2002WO2002083712A8 Transporters and ion channels
11/28/2002WO2002077172A3 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors
11/28/2002WO2002072008A9 Method for treating cancer using a33 specific antibodies and chemotherapeutic agents
11/28/2002WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002WO2002067859A3 Ascorbic acid analogs for metalloradiopharmaceuticals
11/28/2002WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002WO2002057790A3 Methods and compositions for diagnosing and treating a subject having depression
11/28/2002WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002WO2002039997A3 Ace-2 modulating compounds and use thereof
11/28/2002WO2002032936A9 E. histolytica-specific antibodies and clinical uses thereof
11/28/2002WO2002024924A3 Protein phosphatases
11/28/2002WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002WO2002008442A9 Means and methods for raising antibody concentration in compartments of the body of a non human animal
11/28/2002WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002WO2001096393A9 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/28/2002WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002WO2000050070A9 Preparation for the treatment of pigmentation disorders
11/28/2002US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002US20020177693 Chromatographic method for high yield purification and viral inactivation of antibodies
11/28/2002US20020177565 Toso proteins and related molecules which have an inhibitory effect on TNF mediated apoptosis
11/28/2002US20020177553 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002US20020177240 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
11/28/2002US20020177239 Anti-GPE antibodies, their uses, and analytical methods for GPE
11/28/2002US20020177218 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
11/28/2002US20020177213 Tissue plasminogen activator-like protease
11/28/2002US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002US20020177200 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
11/28/2002US20020177191 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
11/28/2002US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002US20020177178 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/28/2002US20020177176 Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
11/28/2002US20020177173 Glycoprotein for use in the treatment of thrombosis
11/28/2002US20020177172 Restoring platelet aggregation in the blood of mammals; obtain sample containing membrane protein, incubate with modulator, monitor aggregation in cells
11/28/2002US20020177170 Generating preferential antibody library; provide amino acid sequence variable segment, compare to lead sequence profile tester protein, evaluate for sequence homology
11/28/2002US20020177165 Secreted and transmembrane polypeptides and nucleic acids encoding
11/28/2002US20020177164 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002US20020177128 Variant of LAV viruses
11/28/2002US20020177126 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
11/28/2002US20020177125 Polypeptide for use in the treatment of viral disease
11/28/2002US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002US20020176867 Fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues, and the vaccine based on fusion protein, which induces efficient immunological memory
11/28/2002US20020176858 Monoclonal antibodies to TGF-BETA
11/28/2002US20020176857 Culturing stromal cells with bone marrow, quantitative determining the concentration of interleukins by comparing to a standard curve; identifying a patient with a multiple myeloma- related plasmaproliferative disorder
11/28/2002US20020176856 Administering an antibody to the mammal, that binds with a specified target epitope of an antigen, associated with a tumor or an infectious agent; having engineered glycosylation site in the constant region of the heavy chain antibodies
11/28/2002US20020176855 Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith
11/28/2002US20020176852 Mitogenic oxygenase regulators
11/28/2002DE10123041A1 New single-chain human antibody fragment, useful for treating or diagnosing hepatitis C virus infection, has affinity for an essential viral protein
11/28/2002CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002CA2448668A1 Modulation of cd200 receptors
11/28/2002CA2448253A1 Human cdnas and proteins and uses thereof
11/28/2002CA2448142A1 Beta-secretase substrates and uses thereof
11/28/2002CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002CA2448092A1 Internalisation of virus into cells
11/28/2002CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002CA2447340A1 Kinases and phosphatases
11/28/2002CA2447338A1 Receptors and membrane-associated proteins
11/28/2002CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002CA2444487A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists